Joseph Anthony Metzinger - 12 May 2025 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Reporting relationship: VP, Chief Accounting Officer
Issuer ticker: DVAX
Reported as of: 12 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 May 2025, 16:08:16 UTC
Next SEC filing: 29 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Joseph A. Metzinger

Key filing fact

Joseph Anthony Metzinger filed Form 4 for DYNAVAX TECHNOLOGIES CORP (DVAX) on 13 May 2025.

Key facts

This page summarizes Joseph Anthony Metzinger's Form 4 filing for DYNAVAX TECHNOLOGIES CORP (DVAX).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 13 May 2025, 16:08.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002067729 Primary reporting owner

Metzinger Joseph Anthony

Relationship: VP, Chief Accounting Officer
Address: C/O DYNAVAX TECHNOLOGIES, 2100 POWELL STREET, SUITE 720, EMERYVILLE
Signature: /s/ Joseph A. Metzinger
Signature date: 13 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DVAX transaction Derivative

Option (Right to Buy)

Award

Transaction value
Shares: +31,500
Change %
Price
Shares after: 31,500
Date: 12 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 31,500
Exercise price: $9.85
Footnotes: F1

DVAX transaction Derivative

Restricted Stock Unit

Award

Transaction value
Shares: +38,182
Change %
Price
Shares after: 38,182
Date: 12 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 38,182
Exercise price
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of May 12, 2025, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.

Footnote F2

Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of May 12, 2025.